Aurobindo Pharma aims to achieve $3 billion in revenues in next two years: Report

14 Jun 2016 Evaluate

Aurobindo Pharma is reportedly aiming to achieve $3 billion in revenues in next two years. In this regard, the company will increase number of launches in the US market. Even though Aurobindo had launched as many as 28 products in the US market in the previous year, it has carried forward 7 ANDA final approvals received during the year for the launch in the current year.

The company as on March, 2016 has filed 398 ANDAs on a cumulative basis, out of which 251 ANDAs were approved including 36 tentative approvals and balance 147 ANDAs are under review by the USFDA.

Aurobindo Pharma Share Price

1199.00 -6.95 (-0.58%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×